Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
Detection of Glioblastoma or Anaplastic Astrocytoma Cells in the Circulation During Surgical Resection
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Listed as NCT00001148, this observational or N/A phase trial focuses on Astrocytoma and Glioblastoma and remains completed. Sponsored by National Institute of Neurological Disorders and Stroke (NINDS), it has been updated 6 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Oct 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
For direct contact, visit the study record on ClinicalTrials.gov .